血清学指标与溃疡性结肠炎严重程度的相关性
The Correlation between Serological Indicators and the Severity of Ulcerative Colitis
摘要: 溃疡性结肠炎(ulcerative colitis, UC)是一种慢性、易复发的自身免疫性疾病，该疾病全球患病率依然处于急速上升趋势，若不及时治疗危及生命的可能。因此早发现、早诊断，早治疗极为重要，近年来很多研究发现外周血多项指标可作为评估病情严重程度的有效指标。本综述可通过阅览多篇文章总结得出ANCA、CRP、ESR、NLR等指标能利用于判断UC病情严重程度的评估。
Abstract: Ulcerative colitis (UC) is a chronic, recurrent autoimmune disease, and the global prevalence of the disease is still on the rise, and it may be life-threatening if left untreated. Therefore, early detection, early diagnosis, and early treatment are extremely important, and in recent years, many studies have found that many indicators of peripheral blood can be used as effective indicators to assess the severity of the disease. This review can summarize through reading multiple articles, and that ANCA, CRP, ESR, NLR and other indicators can be used to judge the severity of UC.
文章引用：则巴古丽, 古丽尼尕尔·吾斯曼, 尼格热木·阿布力克木, 古丽巴哈尔·司马义. 血清学指标与溃疡性结肠炎严重程度的相关性[J]. 临床医学进展, 2023, 13(10): 16245-16250. https://doi.org/10.12677/ACM.2023.13102271

参考文献

[1] Niu, W., Chen, X.Q., Xu, R.L., et al. (2021) Polysaccharides from Natural Resources Exhibit Great Potential in the Treatment of Ulcerative Colitis: A Review. Carbohydrate Polymers, 254, Article ID: 117189. [Google Scholar] [CrossRef] [PubMed]
[2] Lamb, C.A., Kennedy, N.A., Raine, T., et al. (2019) British Society of Gastroenterology Consensus Guidelines on the Management of Inflammatory Bowel Disease in Adults. Gut, 68, S1-S106. [Google Scholar] [CrossRef] [PubMed]
[3] Ng, S.C., Shi, H.Y., Hamidi, N., et al. (2018) Worldwide Incidence and Prevalence of Inflammatory Bowel Disease in the 21st Century: A Systematic Review of Pop-ulation-Based Studies. Lancet, 390, 2769-2778. [Google Scholar] [CrossRef] 
[4] Jones, G.-R., Lyons, M., Plevris, N., et al. (2019) IBD Prevalence in Lothian, Scotland, Derived by Capture-Recapture Methodology. Gut, 68, 1953-1960. [Google Scholar] [CrossRef] [PubMed]
[5] Kaplan, G.G. (2015) The Global Burden of IBD: From 2015 to 2025. Nature Reviews Gastroenterology & Hepatology, 12, 720-727. [Google Scholar] [CrossRef] [PubMed]
[6] Kirsner, J.B. (1988) Historical Aspects of Inflammatory Bowel Disease. Journal of Clinical Gastroenterology, 10, 286-297. [Google Scholar] [CrossRef] [PubMed]
[7] Kaplan, G.G. and Ng, S.C. (2017) Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. Gastroenterology, 152, 313-321. [Google Scholar] [CrossRef] [PubMed]
[8] Quaresma, A.B., Damiao, A.O.M.C., Coy, C.S.R., Magro, D.O., Hino, A.A.F., Valverde, D.A., Panaccione, R., Coward, S.B., Ng, S.C., Kaplan, G.G. and Kotze, P.G. (2022) Temporal Trends in the Epidemiology of Inflammatory Bowel Diseases in the Public Healthcare System in Brazil: A Large Popula-tion-Based Study. The Lancet Regional Health-Americas, 13, Article ID: 100298. [Google Scholar] [CrossRef] [PubMed]
[9] Pasvol, T.J., Horsfall, L., Bloom, S., et al. (2020) Incidence and Prevalence of Inflammatory Bowel Disease in UK Primary Care: A Population-Based Cohort Study. BMJ Open, 10, e036584. [Google Scholar] [CrossRef] [PubMed]
[10] Travis, S.P.L., Schnell, D, Krzeski, P., et al. (2013) Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity. Gastroenterology, 145, 987-995. [Google Scholar] [CrossRef] [PubMed]
[11] Porter, R.J., Kalla, R. and Ho, G.-T. (2020) Ulcerative Colitis: Recent Advances in the Understanding of Disease Pathogenesis. F1000Research, 9, Article No. 294. [Google Scholar] [CrossRef] [PubMed]
[12] Piovani, D., Danese, S., Peyrin-Biroulet, L., et al. (2019) En-vironmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-Analyses. Gastroenterology, 157, 647-659. [Google Scholar] [CrossRef] [PubMed]
[13] Kushkevych, I., Martínková, K., Vítězová, M. and Rittmann, S.K.-M.R. (2021) Intestinal Microbiota and Perspectives of the Use of Meta-Analysis for Comparison of Ulcerative Co-litis Studies. Journal of Clinical Medicine, 10, Article No. 462. [Google Scholar] [CrossRef] [PubMed]
[14] Dordević, D., Jančíková, S., Vítězová, M. and Kushkevych, I. (2020) Hydrogen Sulfide Toxicity in the Gut Environment: Me-ta-Analysis of Sulfate-Reducing and Lactic Acid Bacteria in Inflammatory Processes. Journal of Advanced Research, 27, 55-69. [Google Scholar] [CrossRef] [PubMed]
[15] 余玲. 溃疡性结肠炎主要发病机制研究进展综述[J]. 科技视界, 2023(7): 65-68. [Google Scholar] [CrossRef] 
[16] Kucharzik, T., Dignass, A.U., Atreya, R., et al. (2019) [August 2019-AWMF-Registriernummer: 021-009]. Z Gastroenterol, 57, 1321-1405.
https://pubmed.ncbi.nlm.nih.gov/31739378/
[17] Cui, G. and Yuan, A. (2018) A Systematic Review of Epidemi-ology and Risk Factors Associated with Chinese Inflammatory Bowel Disease. Frontiers in Medicine, 5, Article 183. [Google Scholar] [CrossRef] [PubMed]
[18] Caprilli, R., Viscido, A. and Latella, G. (2007) Current Management of Severe Ulcerative Colitis. Nature Clinical Practice Gastroenterology & Hepatology, 4, 92-101. [Google Scholar] [CrossRef] [PubMed]
[19] Vermeire, S., Van Assche, G. and Rutgeerts, P. (2006) Laboratory Markers in IBD: Useful, Magic, or Unnecessary Toys? Gut, 55, 426-431. [Google Scholar] [CrossRef] [PubMed]
[20] Osada, T., Ohkusa, T., Okayasu, I., et al. (2010) Correlations among Total Colonoscopic Findings, Clinical Symptoms, and Laboratory Markers in Ulcerative Colitis. Journal of Gastroenter-ology & Hepatology, 23, S262-S267. [Google Scholar] [CrossRef] [PubMed]
[21] Vidrich, A., Lee, J., James, E., Cobb, L. and Targan, S. (1995) Segregation of pANCA Antigenic Recognition by DNase Treatment of Neutrophils: Ulcerative Colitis, Type 1 Autoimmune Hepatitis, and Primary Sclerosing Cholangitis. Journal of Clinical Immunology, 15, 293-299. [Google Scholar] [CrossRef] 
[22] Pang, Y., Ruan, H., Wu, D., et al. (2020) Assessment of Clinical Activ-ity and Severity Using Serum ANCA and ASCA Antibodies in Patients with Ulcerative Colitis. Allergy, Asthma & Clin-ical Immunology, 16, Article No. 37. [Google Scholar] [CrossRef] [PubMed]
[23] 阮慧杰. 定量检测血清ANCA和ASCA对UC的临床价值[D]: [硕士学位论文]. 太原: 山西医科大学, 2017.
[24] 荣雨露, 高海晋, 许翠萍. 定量检测血清抗中性粒细胞胞质抗体对溃疡性结肠炎的临床价值[J]. 中华消化杂志, 2020, 40(10): 697-700
[25] Bonneau, J., Dumestre-Perard, C., Rinaudo-Gaujous, M., Genin, C., Sparrow, M., Roblin, X. and Paul, S. (2015) Systematic Review: New Serological Markers (Anti-Glycan, Anti-GP2, Anti-GM-CSF Ab) in the Prediction of IBD Patient Outcomes. Autoimmunity Reviews, 14, 231-245. [Google Scholar] [CrossRef] [PubMed]
[26] Sands, B.E. (2015) Biomarkers of Inflammation in Inflammatory Bowel Disease. Gastroenterology, 149, 1275-1285. [Google Scholar] [CrossRef] [PubMed]
[27] 张袁露, 庄思慧, 张诗颜. 血细胞相关参数在炎症性肠病患者中的变化及临床意义[J]. 检验医学与临床, 2016, 13(6): 837-839.
[28] Torun, S., Tunc, B.D., Suvak, B., et al. (2012) Assessment of Neutrophil-Lymphocyte Ratio in Ulcerative Colitis: A Promising Marker in Predicting Disease Severity. Clinics and Research in Hepatology and Gastroenterology, 36, 491-497. [Google Scholar] [CrossRef] [PubMed]
[29] Cherfane, C.E., Gessel, L., Cirillo, D., et al. (2015) Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity. Inflammato-ry Bowel Diseases, 21, 1062-1065. [Google Scholar] [CrossRef] 
[30] 田景媛, 罗和生. 中性粒细胞/淋巴细胞比值及血小板/淋巴细胞比值在溃疡性结肠炎病情评估中的临床价值[J]. 胃肠病学和肝病学杂志, 2019, 28(3): 291-295.
[31] Ipek, S., Cekic, C., Alper, E., et al. (2015) Can Red Cell Distribution Width Be a Marker of Disease Activity in Ulcerative Co-litis? International Journal of Clinical and Experimental Medicine, 8, 13848-13853.
[32] Oliveira, A.M., Cardoso, F.S., Rodrigues, C.G., et al. (2016) Can Red Cell Distribution Width Be Used as a Marker of Crohn’s Disease Activity? GE Portuguese Journal of Gastroenterology, 23, 6-12. [Google Scholar] [CrossRef] [PubMed]
[33] Hu, D., Ren, J., Wang, G., et al. (2015) Value of Red Cell Distri-bution Width for Assessing Disease Activity in Crohn’s Disease. The American Journal of the Medical Sciences, 349, 42-45. [Google Scholar] [CrossRef] 
[34] Khan, K., Schwarzenberg, S.J., Sharp, H., Greenwood, D. and Weisdorf-Schindele, S. (2002) Role of Serology and Routine Laboratory Tests in Childhood Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 8, 325-329. [Google Scholar] [CrossRef] [PubMed]
[35] Peterson, C.G.B., Sangfelt, P., Wagner, M., et al. (2007) Fecal Levels of Leukocyte Markers Reflect Disease Activity in Patients with Ulcerative Colitis. Scandinavian Journal of Clinical and Laboratory Investigation, 67, 810-820. [Google Scholar] [CrossRef] [PubMed]
[36] Sutherland, A.D., Gearry, R.B. and Frizelle, F.A. (2008) Review of Fecal Biomarkers in Inflammatory Bowel Disease. Diseases of the Colon & Rectum, 51, 1283-1291. [Google Scholar] [CrossRef] [PubMed]
[37] Xue, T.-C., Lan, Z., Xie, X.-Y., et al. (2014) Prognostic Signifi-cance of the Neutrophil-to-Lymphocyte Ratio in Primary Liver Cancer: A Meta-Analysis. PLOS ONE, 9, e96072. [Google Scholar] [CrossRef] [PubMed]
[38] Gökmen, F., Akbal, A., Reşorlu, H., et al. (2015) Neutro-phil-Lymphocyte Ratio Connected to Treatment Options and Inflammation Markers of Ankylosing Spondylitis. Journal of Clinical Laboratory Analysis, 29, 294-298. [Google Scholar] [CrossRef] [PubMed]
[39] Posul, E., Yilmaz, B., Aktas, G. and Kurt, M. (2015) Does Neutro-phil-to-Lymphocyte Ratio Predict Active Ulcerative Colitis? Wiener Klinische Wochenschrift, 127, 262-265. [Google Scholar] [CrossRef] [PubMed]
[40] Celikbilek, M., Dogan, S., Ozbakır, O., et al. (2013) Neutro-phil-Lymphocyte Ratio as a Predictor of Disease Severity in Ulcerative Colitis. Journal of Clinical Laboratory Analysis, 27, 72-76. [Google Scholar] [CrossRef] [PubMed]

为你推荐